About Us

Lantheus Medical Imaging – COVID-19

about us lantheus medical imaging

View 5/26/2020 Update Regarding COVID-19

We want to update you on our response to COVID-19 and supporting the “Opening Up America
Again” guidelines currently underway in many states. As always, we remain committed to the
health and safety of our employees, their families, and our partners, customers, and their patients.
We take our role as a leader in innovative diagnostic imaging agents and products as both a
privilege and responsibility and we are taking the following actions.

Ensuring the Safety of  Our Teams and Communities

  • We continue to follow guidance from the CDC, Massachusetts, and other relevant states and municipalities and operate a “Pandemic Response Team” to implement and oversee appropriate precautions to minimize the spread of COVID-19 in our teams and communities.
  • We continue to have all non-critical employees and contractors work-remotely and avoid work-related travel.
  • We have established a “Return to LMI Facilities Team” to develop plans for employees to safely return to all LMI facilities.
  • We are also requiring “self-reporting” by all employees and contractors, including those working remotely, to monitor those who may be at risk of contracting or transmitting COVID-19.
  • Vew the recent Lantheus webinar: COVID-19: Clinical Experiences from the Front Line in NYC

Ensuring Business Continuity to Support our Customers and Patients

  • We continue to fulfill our “essential” role of providing diagnostic imaging agents and products to our customers – we have more than 100 critical manufacturing, supply, and quality employees and contractors in Massachusetts, Canada, and Puerto Rico supporting these activities on-site at LMI facilities.
  • We are returning most of our manufacturing to pre-COVID schedules and are in regular contact with our suppliers and air and ground carriers, to prepare for the increase of procedures in-line with the “Opening Up America Again” guidelines. We expect to be able to supply our customer’s individual needs as they ramp-up procedure volumes.
  • We remain committed to supporting clinicians and are available to them by phone, email, or virtual programs as necessary. As state and facility guidelines allow, we are planning for our field teams to be available for in-person meetings, subject to appropriate precautions including PPE and written customer approval.
  • We continue to communicate with relevant health and regulatory authorities and industry groups to ensure that we stay up-to-date on this evolving situation.
  • As always, our sales and customer service representatives (+1.800.299.3431) remain available for questions or additional information.
  • Vew the recent Lantheus webinar: COVID-19: Clinical Experiences from the Front Line in NYC

We send our thoughts and prayers to those affected by COVID-19 and will continue to do our part to keep our teams and communities safe and support our customers and patients as we “Open Up America” and other geographies. As always, we thank you for your business.

Questions about Lantheus and COVID-19?  Contact us